Article info
PDFOriginal research
Circulating miR-146a expression predicts early treatment response to imatinib in adult chronic myeloid leukemia
- Correspondence to Dr Eman M Habib, Clinical Pathology, Faculty of Medicine, Kafr el-Sheikh University, Kafr el-Sheikh, Egypt; eman.habeeb{at}yahoo.com; Dr Muhammad Tarek Abdel Ghafar, Clinical Pathology Department, Faculty of Medicine-Tanta University, Tanta, Egypt; mohammedtarek5514{at}yahoo.com
Citation
Circulating miR-146a expression predicts early treatment response to imatinib in adult chronic myeloid leukemia
Publication history
- Accepted October 20, 2020
- First published November 10, 2020.
Online issue publication
January 25, 2021
Article Versions
- Previous version (10 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© American Federation for Medical Research 2021. No commercial re-use. See rights and permissions. Published by BMJ.